EMCDDA Home
  • EN
Search

Table DUP-4. Prevalence of injecting drug use within prison among prisoners, 2000–11

Part (i) Most recent data available from survey/routine monitoring (%)

Countryyearsource/ referenceSampleAny illicit drugCocaineHeroinAmphetaminesEcstasy
Belgium(d)2010112512::::
Bulgaria(d)2006525623:3::
Czech Republic(a)2010116688::::
Denmark:::::::::
Germany(a)20071145722::::
Estonia:::::::::
Ireland:::::::::
Greece:::::::::
Spain(c)2006149343::::
France:::::::::
Italy:::::::::
Cyprus:::::::::
Latvia(a)20101196510(1)19142
Lithuania:::::::::
Luxembourg(a)2005124631::::
Hungary(a)2008(2)15030.7::::
Malta:::::::::
Netherlands:::::::::
Austria:::::::::
Poland(a)200121189(3)3::::
Portugal(a)20071198611(4)22::
Romania:::::::::
Slovenia:::::::::
Slovakia:::::::::
Finland:::::::::
Sweden:::::::::
United Kingdom(d)2004-05(5)15057::::
United Kingdom(a)2011(7)1042437::::
Croatia:::::::::
Turkey:::::::::
Norway:::::::::
 

Notes:

(a) Lifetime injecting drug use. (b) Last year injecting drug use. (c) Last month injecting drug use. (d) Refer to part (ii).

(1) 2003 national survey in 11 (out of 15) prisons with at least 100 convicted persons (n = 2867).

(2) Also available: last year injecting use of any illicit drug 0.2%

(3) Only adult males.

(4) 2001 nationwide survey (47 prisons) in a random sample of on remand and convicted prisoners (n = 2057).

(5) England, only females.

(6) England and Wales.

(7) Scotland. Also available: last month injecting use of any illicit drug 1%

Source:

For methodological information, and previous surveys please refer to Reitox national focal points. See Table DUP-04 part (ii)

For access to sources and bibliographic references, refer to Table DUP-0.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013